Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05652023 · ClinicalTrials.gov registry record
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
A clinical trial of Overactive Bladder and Bladder Dysfunction, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 2,023
- Enrollment target
- 1
- Study location
NCT05652023: Recruiting study of Overactive Bladder and Bladder Dysfunction, sponsored by Mayo Clinic.
NCT05652023 is a study of Overactive Bladder and Bladder Dysfunction that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 2,023 participants, above the 163-participant average among 46 other Overactive Bladder trials with a reported enrollment target (1141% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05652023, a study of Overactive Bladder and Bladder Dysfunction, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 2,023 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Primary Outcome
Will be reported including 95% confidence intervals derived from the cross-validation procedure.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,023 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2028-12-20 |
What NCT05652023 shows while recruiting
NCT05652023 is an observational study that tracks outcomes without assigning an intervention. Its 2,023 participants enrollment target places it among the larger protocols in the corpus, above the 163-participant average among 46 other Overactive Bladder trials with a reported enrollment target (1141% higher).
The record links to 3 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 0 interventions.
NCT05652023 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05652023 about?
NCT05652023 is a clinical study titled "Noninvasive Ultrasound Assessment of Detrusor Dysfunction". The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
What is the current status of trial NCT05652023?
This trial is currently recruiting. The enrollment target is 2,023 participants. The study started on 2023-04-20. Estimated completion is 2028-12-20.
What conditions does trial NCT05652023 study?
This clinical trial studies the following conditions: Overactive Bladder, Bladder Dysfunction, BPH With Urinary Obstruction.
Who is sponsoring clinical trial NCT05652023?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05652023 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05652023's enrollment target sits among peer trials
2,023 1st of 46 higher than 46 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI